Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.4.25.1 (
proteasome
)
28,817
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Tumor suppressor genes play a key role in cancer pathogenesis. Through massive expression profiling we identified
CHAC2
as a frequently downregulated gene in gastric and colorectal cancers. Immunohistochemistry and western blot revealed that
CHAC2
was downregulated in most tumor tissues, and 3-year survival rate of patients with high
CHAC2
expression was significantly higher than that of patients with low
CHAC2
expression (P<0.001 and P=0.001, respectively). The data of univariate analysis and multivariate analysis suggested that
CHAC2
could serve as an independent prognostic marker. Our results showed for the first time that
CHAC2
was degraded by the ubiquitin-
proteasome
pathway and
CHAC2
expression inhibited tumor cell growth, proliferation, migration in vitro and in vivo. Mechanistic study showed that
CHAC2
induced mitochondrial apoptosis and autophagy through unfolded protein response. So in gastric and colorectal cancer
CHAC2
acted as a tumor suppressor and might have therapeutic implication for patients.
...
PMID:CHAC2, downregulated in gastric and colorectal cancers, acted as a tumor suppressor inducing apoptosis and autophagy through unfolded protein response. 2883 56